secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amylyx Pharmaceuticals, Inc. (AMLX)
CIK:        0001658551
Form:       8-K
Filed at:   2022-11-02T23:59:59+00:00
Accession:  0001193125-22-275812
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Isaac Cheng resigns from Amylyx board effective Nov 1, 2022
--------------------------------------------------------------------

- Isaac Cheng, MD, resigned from the board of directors on November 1, 2022.
- Resignation is not due to any disagreement with the company on operations, policies, or accounting.
- Board size reduced by one; no replacement named in the filing.
- Company thanked Dr. Cheng for his service and contributions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1658551/000119312522275812/0001193125-22-275812-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1658551/000119312522275812/d374833d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-275812

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer